IL-1 family members in cancer; two sides to every story
Baker, Kevin J.
Houston, Aileen M.
Brint, Elizabeth K.
The IL-1 family of cytokines currently comprises of seven ligands with pro-inflammatory activity (IL-1α and IL-1β, IL-18, IL-33, IL-36α, IL-36β, IL-36γ) as well as two ligands with anti-inflammatory activity (IL-37, IL-38). These cytokines are known to play a key role in modulating both the innate and adaptive immunes response, with dysregulation linked to a variety of autoimmune and inflammatory diseases. Given the increasing appreciation of the link between inflammation and cancer, the role of several members of this family in the pathogenesis of cancer has been extensively investigated. In this review, we highlight both the pro- and anti-tumorigenic effects identified for almost all members of this family, and explore potential underlying mechanisms accounting for these divergent effects. Such dual functions need to be carefully assessed when developing therapeutic intervention strategies targeting these cytokines in cancer.
Interleukin-1 (IL-1) , Inflammation , Cancer , IL-18 , IL-33 , IL-36 family interleukins , Predicts poor prognosis , Inhibits tumor growth , Natural killer cells , Pancreatic cancer , Ovarian cancer , T-cells , Serum interleukin-18 , Metastatic phenotype , Acquired immunity
Baker, K. J., Houston, A. and Brint, E. (2019) 'IL-1 Family Members in Cancer; Two Sides to Every Story', Frontiers in Immunology, 10, 1197 (16 pp). doi: 10.3389/fimmu.2019.01197
© 2019 Baker, Houston and Brint. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.